Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Astera Labs (ALAB) EBIT (2023 - 2025)

Astera Labs has reported EBIT over the past 3 years, most recently at $67.0 million for Q4 2025.

  • For the quarter ending Q4 2025, EBIT rose 46398.61% year-over-year to $67.0 million, compared with a TTM value of $173.4 million through Dec 2025, up 249.42%, and an annual FY2025 reading of $173.4 million, up 249.42% over the prior year.
  • EBIT came in at $67.0 million for Q4 2025, up from $55.4 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $67.0 million in Q4 2025 to a low of -$83.0 million in Q1 2024.
  • Median EBIT over the past 3 years was -$916500.0 (2023), compared with a mean of $2.3 million.
  • The sharpest move saw EBIT crashed 349.97% in 2024, then surged 46398.61% in 2025.
  • Over 3 years, EBIT stood at $9.0 million in 2023, then plummeted by 98.4% to $144000.0 in 2024, then surged by 46398.61% to $67.0 million in 2025.
  • Per Business Quant, the three most recent readings for ALAB's EBIT are $67.0 million (Q4 2025), $55.4 million (Q3 2025), and $39.8 million (Q2 2025).